Delayed presentation of surgically induced scleral necrosis after I-BRITE procedure treated with immunosuppressive therapy
Article Sidebar
Main Article Content
Abstract
Surgically induced scleral necrosis (SISN) is an uncommon complication of ocular procedures. Cosmetic eye-whitening surgery involves conjunctival and Tenon’s capsule dissection, cautery, and mitomycin C application. We report the case of a 36-year-old white woman referred to our clinic for severe pain, scleral inflammation, and necrosis in both eyes 9 years after I-BRITE, an elective eye-whitening procedure. An extensive workup yielded negative results. The patient improved with aggressive lubrication and topical and high-dose systemic prednisone (60 mg), with recurrence upon steroid tapering. Concomitant weekly methotrexate was added, resulting in inflammatory control and allowing discontinuance of topical and oral steroids.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Lee S, Go J, Rhiu S, et al. Cosmetic regional conjunctivectomy with postoperative mitomycin C application with or without bevacizumab injection. Am J Ophthalmol 2013;156:616-22.e3. DOI: https://doi.org/10.1016/j.ajo.2013.01.035
Leung TG, Dunn JP, Akpek EK, Thorne JE. Necrotizing scleritis as a complication of cosmetic eye whitening procedure. J Ophthalmic Inflamm Infect 2013;3:39. DOI: https://doi.org/10.1186/1869-5760-3-39
Vo RC, Stafeeva K, Aldave AJ, et al. Complications related to a cosmetic eye-whitening procedure. Am J Ophthalmol 2014;158:967-73. DOI: https://doi.org/10.1016/j.ajo.2014.07.032
Moshirfar M, McCaughey MV, Fenzl CR, Santiago-Caban L, Kramer GD, Mamalis N. Delayed manifestation of bilateral scleral thinning after I-BRITE((R)) procedure and review of literature for cosmetic eye-whitening procedures. Clin Ophthalmol 2015;9:445-51. DOI: https://doi.org/10.2147/OPTH.S78390
Ji YW, Park SY, Jung JW, et al. Necrotizing scleritis after cosmetic conjunctivectomy with mitomycin C. Am J Ophthalmol 2018;194:72-81. DOI: https://doi.org/10.1016/j.ajo.2018.07.008
Romero-Morales VA, Marchese A, Miserocchi E, et al. Pyogenic granuloma after cosmetic eye whitening. Arch Soc Esp Oftalmol (Engl Ed) 2021;96:89-92. DOI: https://doi.org/10.1016/j.oftale.2020.06.018
Rhiu S, Shim J, Kim EK, et al. Complications of cosmetic wide conjunctivectomy combined with postsurgical mitomycin C application. Cornea 2012;31:245-52. DOI: https://doi.org/10.1097/ICO.0B013E3182343073
Tran AQ, Hoeppner C, Venkateswaran N, et al. Complications of cosmetic eye whitening. Cutis 2017;100:E24-E6.
Ruiz-Lozano RE, Garza-Garza LA, Davila-Cavazos O, et al. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: a review. Surv Ophthalmol 2021;66:594-611. DOI: https://doi.org/10.1016/j.survophthal.2020.12.008
Mahmood S, Suresh PS, Carley F, et al. Surgically induced necrotising scleritis: report of a case presenting 51 years following strabismus surgery. Eye (Lond) 2002;16:503-4. DOI: https://doi.org/10.1038/sj.eye.6700033
Kim BH. Regional conjunctivectomy with postoperative mitomycin C to treat chronic hyperemic conjunctiva. Cornea 2012;31:236-44. DOI: https://doi.org/10.1097/ICO.0b013e318211467d
Galanopoulos A, Snibson G, O’Day J. Necrotising anterior scleritis after pterygium surgery. Aust N Z J Ophthalmol 1994;22:167-73. DOI: https://doi.org/10.1111/j.1442-9071.1994.tb01712.x
Alsagoff Z, Tan DT, Chee SP. Necrotising scleritis after bare sclera excision of pterygium. Br J Ophthalmol 2000;84:1050-2. DOI: https://doi.org/10.1136/bjo.84.9.1050
Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997;115:969-74. DOI: https://doi.org/10.1001/archopht.1997.01100160139001
Cheng HC, Tseng SH, Kao PL, Chen FK. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 2001;20:24-9. DOI: https://doi.org/10.1097/00003226-200101000-00004
Ivanusic JJ, Wood RJ, Brock JA. Sensory and sympathetic innervation of the mouse and guinea pig corneal epithelium. J Comp Neurol 2013;521:877-93. DOI: https://doi.org/10.1002/cne.23207
Acosta MC, Peral A, Luna C, et al. Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers. Invest Ophthalmol Vis Sci 2004;45:2333-6. DOI: https://doi.org/10.1167/iovs.03-1366
Denoyer A, Landman E, Trinh L, et al. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK. Ophthalmology 2015;122:669-76. DOI: https://doi.org/10.1016/j.ophtha.2014.10.004
Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 2017;124:S4-S13. DOI: https://doi.org/10.1016/j.ophtha.2017.07.010
Chan TC, Ye C, Chan KP, et al. Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes. Br J Ophthalmol 2016;100:1188-91. DOI: https://doi.org/10.1136/bjophthalmol-2015-307607
Seo KY, Lee HK, Kim EK, Lee JH. Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis. Ophthalmic Res 2006;38:66-70. DOI: https://doi.org/10.1159/000090010
Watson PG, Young RD. Scleral structure, organisation and disease: a review. Exp Eye Res 2004;78:609-23. DOI: https://doi.org/10.1016/S0014-4835(03)00212-4
Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery: a clinicopathologic study. Ophthalmology 1991;98:1720-6. DOI: https://doi.org/10.1016/S0161-6420(91)32062-1
Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology 1991;98:472-9. DOI: https://doi.org/10.1016/S0161-6420(91)32280-2
Pisetsky DS. Immune phenotypes in individuals positive for antinuclear antibodies: the impact of race and ethnicity. J Allergy Clin Immunol 2020;146:1346-8. DOI: https://doi.org/10.1016/j.jaci.2020.09.006